Tags Archive Navigation
icon
-
Featured NewsNovartis employs creative deal structure to establish Borealis Biosciences – divests legacy Chinook site, invests to form new company and engages in R&D collaboration
-
Featured NewsNovartis Financial Results – Q2 2024 -
Featured NewsOur next era -
Featured NewsNovartis Financial Results – Q3 2023 -
Featured NewsNovartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
-
Featured NewsNovartis’ Giving & Volunteering wins ACCP’s 2023 Corporate Social Impact Team of the Year Award
-
Featured NewsNovartis Financial Results – Q2 2023 -
Featured NewsNovartis Financial Results – Q1 2023 -
Featured NewsNovartis unwavering in support one year on from the start of the war in Ukraine
-
Featured NewsNovartis releases emergency funding of USD 1 million for people in Turkey and Syria, and launches employee donation and volunteering programs
-
Featured NewsNovartis announces support for people affected by the earthquake in Turkey and Syria
-
Featured NewsNovartis 2022 Financial Results
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 15
- › Next page